COVID-19 Recombinant Protein Vaccine Market Report

China COVID-19 Recombinant Protein Vaccine Industry Market Research Report 2023-2029

  • POSTDATE：Sep 19, 2023
  • PAGES：222
  • REPORT CODE：GMM1809796
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the COVID-19 Recombinant Protein Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Johnson & Johnson

    • Novavax

    • Sanofi

    • GSK

    • Pukang Biologic Technology

    • Clover Biopharmaceuticals

    By Type:

    • Clinical II

    • Preclinical

    • Being Developed

    • Clinical I

    By Application:

    • Hospital

    • Other

    • Academic And Research Organizations

    • Pharmaceutical And Biotechnology Companies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China COVID-19 Recombinant Protein Vaccine Market Overview 2018-2029

    • 1.1 China COVID-19 Recombinant Protein Vaccine Industry Development Overview

    • 1.2 China COVID-19 Recombinant Protein Vaccine Industry Development History

    • 1.3 China COVID-19 Recombinant Protein Vaccine Industry Market Size (2018-2029)

    • 1.4 China COVID-19 Recombinant Protein Vaccine Market Analysis by Type from Production Side

      • 1.4.1 China COVID-19 Recombinant Protein Vaccine Production Volume, Production Value and Growth Rate of Clinical II (2018-2029)

      • 1.4.2 China COVID-19 Recombinant Protein Vaccine Production Volume, Production Value and Growth Rate of Preclinical (2018-2029)

      • 1.4.3 China COVID-19 Recombinant Protein Vaccine Production Volume, Production Value and Growth Rate of Being Developed (2018-2029)

      • 1.4.4 China COVID-19 Recombinant Protein Vaccine Production Volume, Production Value and Growth Rate of Clinical I (2018-2029)

    • 1.5 China COVID-19 Recombinant Protein Vaccine Market Analysis by Application from Consumption End

      • 1.5.1 China COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.3 China COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate of Academic And Research Organizations (2018-2029)

      • 1.5.4 China COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate of Pharmaceutical And Biotechnology Companies (2018-2029)

    • 1.6 China COVID-19 Recombinant Protein Vaccine Market Analysis by Region

      • 1.6.1 North China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

    Chapter 2 China COVID-19 Recombinant Protein Vaccine Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on COVID-19 Recombinant Protein Vaccine Market Status and Competition at home and abroad in 2023

      • 2.2.2 China COVID-19 Recombinant Protein Vaccine Market Status and Competition Analysis in 2023

      • 2.2.3 China COVID-19 Recombinant Protein Vaccine Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China COVID-19 Recombinant Protein Vaccine Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on COVID-19 Recombinant Protein Vaccine Industry Development

    Chapter 3 COVID-19 Recombinant Protein VaccineIndustry Chain Analysis

    • 3.1 COVID-19 Recombinant Protein Vaccine Industry Chain

    • 3.2 COVID-19 Recombinant Protein Vaccine Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the COVID-19 Recombinant Protein Vaccine Market

    • 3.3 COVID-19 Recombinant Protein Vaccine Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the COVID-19 Recombinant Protein Vaccine Market

    Chapter 4 China COVID-19 Recombinant Protein Vaccine Market, by Type

    • 4.1 China COVID-19 Recombinant Protein Vaccine Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China COVID-19 Recombinant Protein Vaccine Total Production Volume and Growth Rate from Production Side

    • 4.5 China COVID-19 Recombinant Protein Vaccine Production Volume and Growth Rate, by Type

      • 4.5.1 China COVID-19 Recombinant Protein Vaccine Production Volume and Growth Rate of Clinical II

      • 4.5.2 China COVID-19 Recombinant Protein Vaccine Production Volume and Growth Rate of Preclinical

      • 4.5.3 China COVID-19 Recombinant Protein Vaccine Production Volume and Growth Rate of Being Developed

      • 4.5.4 China COVID-19 Recombinant Protein Vaccine Production Volume and Growth Rate of Clinical I

    Chapter 5 China COVID-19 Recombinant Protein Vaccine Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China COVID-19 Recombinant Protein Vaccine Total Market Size and Growth Rate from Consumption End

    • 5.5 China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate, by Application

      • 5.5.1 China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Hospital

      • 5.5.2 China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Other

      • 5.5.3 China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Academic And Research Organizations

      • 5.5.4 China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Pharmaceutical And Biotechnology Companies

    Chapter 6 China COVID-19 Recombinant Protein Vaccine Market, by Region

    • 6.1 China COVID-19 Recombinant Protein Vaccine Production Volume and Production Value, by Region

    • 6.2 China COVID-19 Recombinant Protein Vaccine Sales Volume and Sales Value, by Region

    Chapter 7 North China COVID-19 Recombinant Protein Vaccine Market Analysis

    • 7.1 North China COVID-19 Recombinant Protein Vaccine Market, by Type

    • 7.2 North China COVID-19 Recombinant Protein Vaccine Market, by Application

    Chapter 8 Central China COVID-19 Recombinant Protein Vaccine Market Analysis

    • 8.1 Central China COVID-19 Recombinant Protein Vaccine Market, by Type

    • 8.2 Central China COVID-19 Recombinant Protein Vaccine Market, by Application

    Chapter 9 South China COVID-19 Recombinant Protein Vaccine Market Analysis

    • 9.1 South China COVID-19 Recombinant Protein Vaccine Market, by Type

    • 9.2 South China COVID-19 Recombinant Protein Vaccine Market, by Application

    Chapter 10 East China COVID-19 Recombinant Protein Vaccine Market Analysis

    • 10.1 East China COVID-19 Recombinant Protein Vaccine Market, by Type

    • 10.2 East China COVID-19 Recombinant Protein Vaccine Market, by Application

    Chapter 11 Northeast China COVID-19 Recombinant Protein Vaccine Market Analysis

    • 11.1 Northeast China COVID-19 Recombinant Protein Vaccine Market, by Type

    • 11.2 Northeast China COVID-19 Recombinant Protein Vaccine Market, by Application

    Chapter 12 Southwest China COVID-19 Recombinant Protein Vaccine Market Analysis

    • 12.1 Southwest China COVID-19 Recombinant Protein Vaccine Market, by Type

    • 12.2 Southwest China COVID-19 Recombinant Protein Vaccine Market, by Application

    Chapter 13 Northwest China COVID-19 Recombinant Protein Vaccine Market Analysis

    • 13.1 Northwest China COVID-19 Recombinant Protein Vaccine Market, by Type

    • 13.2 Northwest China COVID-19 Recombinant Protein Vaccine Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Johnson & Johnson

        • 14.1.1 Johnson & Johnson Company Profile

        • 14.1.2 Johnson & Johnson COVID-19 Recombinant Protein Vaccine Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Novavax

        • 14.2.1 Novavax Company Profile

        • 14.2.2 Novavax COVID-19 Recombinant Protein Vaccine Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Sanofi

        • 14.3.1 Sanofi Company Profile

        • 14.3.2 Sanofi COVID-19 Recombinant Protein Vaccine Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 GSK

        • 14.4.1 GSK Company Profile

        • 14.4.2 GSK COVID-19 Recombinant Protein Vaccine Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Pukang Biologic Technology

        • 14.5.1 Pukang Biologic Technology Company Profile

        • 14.5.2 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Clover Biopharmaceuticals

        • 14.6.1 Clover Biopharmaceuticals Company Profile

        • 14.6.2 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Market Performance

        • 14.6.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 COVID-19 Recombinant Protein Vaccine Industry Research Conclusions

    • 15.2 COVID-19 Recombinant Protein Vaccine Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China COVID-19 Recombinant Protein Vaccine Industry Market Size (2018-2029)

    • Figure China COVID-19 Recombinant Protein Vaccine Production Volume, Production Value and Growth Rate of Clinical II (2018-2029)

    • Figure China COVID-19 Recombinant Protein Vaccine Production Volume, Production Value and Growth Rate of Preclinical (2018-2029)

    • Figure China COVID-19 Recombinant Protein Vaccine Production Volume, Production Value and Growth Rate of Being Developed (2018-2029)

    • Figure China COVID-19 Recombinant Protein Vaccine Production Volume, Production Value and Growth Rate of Clinical I (2018-2029)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate of Academic And Research Organizations (2018-2029)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate of Pharmaceutical And Biotechnology Companies (2018-2029)

    • Figure North China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Central China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

    • Figure South China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

    • Figure East China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Northeast China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Southwest China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Northwest China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate from 2018-2029

    • Figure COVID-19 Recombinant Protein Vaccine Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China COVID-19 Recombinant Protein Vaccine Market Share by Type in 2018

    • Figure China COVID-19 Recombinant Protein Vaccine Market Share by Type in 2023

    • Figure China COVID-19 Recombinant Protein Vaccine Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China COVID-19 Recombinant Protein Vaccine Production Volume and Growth Rate of Clinical II (2018-2023)

    • Figure China COVID-19 Recombinant Protein Vaccine Production Volume and Growth Rate of Preclinical (2018-2023)

    • Figure China COVID-19 Recombinant Protein Vaccine Production Volume and Growth Rate of Being Developed (2018-2023)

    • Figure China COVID-19 Recombinant Protein Vaccine Production Volume and Growth Rate of Clinical I (2018-2023)

    • Figure China COVID-19 Recombinant Protein Vaccine Market Share by Application in 2018

    • Figure China COVID-19 Recombinant Protein Vaccine Market Share by Application in 2023

    • Figure China COVID-19 Recombinant Protein Vaccine Total Market Size and Growth Rate from Consumption End

    • Figure China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Other (2018-2023)

    • Figure China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Academic And Research Organizations (2018-2023)

    • Figure China COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Pharmaceutical And Biotechnology Companies (2018-2023)

    • Table China COVID-19 Recombinant Protein Vaccine Production Volume by Region (2018-2023)

    • Table China COVID-19 Recombinant Protein Vaccine Production Volume Share by Region (2018-2023)

    • Figure China COVID-19 Recombinant Protein Vaccine Production Volume Share by Region (2018-2023)

    • Table China COVID-19 Recombinant Protein Vaccine Production Value by Region (2018-2023)

    • Table China COVID-19 Recombinant Protein Vaccine Production Value Share by Region (2018-2023)

    • Figure China COVID-19 Recombinant Protein Vaccine Production Value Share by Region (2018-2023)

    • Table China COVID-19 Recombinant Protein Vaccine Sales Volume by Region (2018-2023)

    • Table China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Region (2018-2023)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Region (2018-2023)

    • Table China COVID-19 Recombinant Protein Vaccine Sales Value by Region (2018-2023)

    • Table China COVID-19 Recombinant Protein Vaccine Sales Value Share by Region (2018-2023)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Value Share by Region (2018-2023)

    • Table North China COVID-19 Recombinant Protein Vaccine Production Volume by Type (2018-2023)

    • Table North China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Figure North China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Table North China COVID-19 Recombinant Protein Vaccine Sales Volume by Application (2018-2023)

    • Table North China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Figure North China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Table Central China COVID-19 Recombinant Protein Vaccine Production Volume by Type (2018-2023)

    • Table Central China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Figure Central China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Table Central China COVID-19 Recombinant Protein Vaccine Sales Volume by Application (2018-2023)

    • Table Central China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Central China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Table South China COVID-19 Recombinant Protein Vaccine Production Volume by Type (2018-2023)

    • Table South China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Figure South China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Table South China COVID-19 Recombinant Protein Vaccine Sales Volume by Application (2018-2023)

    • Table South China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Figure South China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Table East China COVID-19 Recombinant Protein Vaccine Production Volume by Type (2018-2023)

    • Table East China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Figure East China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Table East China COVID-19 Recombinant Protein Vaccine Sales Volume by Application (2018-2023)

    • Table East China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Figure East China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Table Northeast China COVID-19 Recombinant Protein Vaccine Production Volume by Type (2018-2023)

    • Table Northeast China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Figure Northeast China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Table Northeast China COVID-19 Recombinant Protein Vaccine Sales Volume by Application (2018-2023)

    • Table Northeast China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Northeast China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Table Southwest China COVID-19 Recombinant Protein Vaccine Production Volume by Type (2018-2023)

    • Table Southwest China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Figure Southwest China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Table Southwest China COVID-19 Recombinant Protein Vaccine Sales Volume by Application (2018-2023)

    • Table Southwest China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Southwest China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Table Northwest China COVID-19 Recombinant Protein Vaccine Production Volume by Type (2018-2023)

    • Table Northwest China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Figure Northwest China COVID-19 Recombinant Protein Vaccine Production Volume Share by Type (2018-2023)

    • Table Northwest China COVID-19 Recombinant Protein Vaccine Sales Volume by Application (2018-2023)

    • Table Northwest China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Northwest China COVID-19 Recombinant Protein Vaccine Sales Volume Share by Application (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson COVID-19 Recombinant Protein Vaccine Revenue, Price and Gross (2018-2023)

    • Table Novavax Company Profile

    • Table Novavax COVID-19 Recombinant Protein Vaccine Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi COVID-19 Recombinant Protein Vaccine Revenue, Price and Gross (2018-2023)

    • Table GSK Company Profile

    • Table GSK COVID-19 Recombinant Protein Vaccine Revenue, Price and Gross (2018-2023)

    • Table Pukang Biologic Technology Company Profile

    • Table Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Revenue, Price and Gross (2018-2023)

    • Table Clover Biopharmaceuticals Company Profile

    • Table Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US